News

UCSF Scientists Win Pew Awards for Cancer and Neuroscience Research

Three UC San Francisco scientists have received 2024 Pew awards to fund their research in neuroscience and cancer. They include a cognitive scientist, Vijay Mohan K Namboodiri, PhD, who is challenging the reigning theory of learning; Justin Eyquem, PhD, a bioengineer who aims to build cancer

UCSF Treats First Patient with Homegrown Chimeric Antigen Receptor (CAR) T-cell Therapy

This month marked an important milestone for UCSF faculty and clinicians working to take on the challenge of glioblastoma multiforme (GBM). They treated their first patient with a promising chimeric antigen receptor (CAR) T-cell therapy that was fully conceived, designed, optimized and manufactured

How the Cell Cycle Orchestra Plays an Unexpected New Tune

The awe-inspiring process of cell division can turn a fertilized egg into a baby – or a cancerous cell into a malignant tumor. With so much at stake, nature keeps it tightly controlled in a process called the cell cycle that scientists thought they thoroughly understood. But now it turns out there

UCSF Health Cancer Experts Featured at Premier Cancer Meeting

Oncology specialists from around the world will come together for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest developments in cancer care, research, technology and education. The meeting will feature over 200 sessions complementing this year’s theme,

UCSF Health Reaches 15,000 Robotic Surgeries

Gastrointestinal cancer surgeons at the UC San Francisco have performed the health system’s 15,000th robotically assisted minimally invasive surgery, making it the first University of California health center to reach this milestone. UCSF Health has the busiest robotic surgery program in the UC

The Biggest Energy Users in Cancer Treatment Aren’t What You Think

Energy expended for hospital and clinic electricity, climate control and ventilation is by far the biggest source of greenhouse gas emissions in radiotherapy, a treatment used in more than half of cancer cases, a new study found. The Lancet Oncology study, led by UC San Francisco researchers, sought

New UCSF Study to Find out What Drives Cancer in Asian Americans

UC San Francisco researchers have received $12.45 million from the National Cancer Institute (NCI) to lead the first long-term study of cancer among Asian Americans, a highly diverse yet understudied group. Despite a growing incidence of cancers that in some cases exceed those of other groups, there